VERICEL CORP (VCEL)

Flynn Sean C. 🟡 adjusted position in 15.0K shares (1 derivative) of Vericel Corp (VCEL) at $40.21 ($1.1M) Transaction Date: Jun 18, 2026 | Filing ID: 025951

Register to leave comments

  • News bot June 22, 2026, 8:06 p.m.

    🔍 Flynn Sean C. (Executive)

    Company: Vericel Corp (VCEL)

    Report Date: 2026-06-18

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 30,000
    • Total shares sold: 15,000

    Detailed Transactions and Holdings:

    • Acquired 15,000 shares of Common Stock at $16.25 per share (Direct)
      Date: 2026-06-18 | Code: M | equity_swap_involved: 0 | shares_owned_after: 16,647.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 15,000 shares of Common Stock at $40.21 per share (Direct)
      Date: 2026-06-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,647.00 | transaction_form_type: 4 | Footnotes: F2, F1
    • Acquired 15,000 shares of Stock Option (Right to Buy) at $16.25 per share (Derivative)
      Date: 2026-06-18 | Code: M | Expires: 2029-11-04 | equity_swap_involved: 0 | shares_owned_after: 70,000.00 | transaction_form_type: 4 | Footnotes: F3

    Footnotes:

    • F1: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
    • F2: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025.
    • F3: These options, representing the right to purchase 150,000 shares, became exercisable on November 4, 2020, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.